How many vials of Enhertu (fam‑trastuzumab deruxtecan‑nxki) are required per infusion session?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Number of Enhertu Vials Per Infusion Session

The number of vials required per Enhertu infusion session depends on the patient's weight and the prescribed dose, with most patients requiring multiple vials since each vial contains only 100 mg and the standard dose is 5.4 mg/kg every 3 weeks.

Dosing and Vial Calculation

Standard dosing for Enhertu is 5.4 mg/kg administered intravenously every 21 days (3 weeks) 1. Each single-dose vial contains 100 mg of fam-trastuzumab deruxtecan-nxki 1.

Calculation Algorithm:

  1. Determine patient weight in kilograms
  2. Calculate total dose needed: Weight (kg) × 5.4 mg/kg
  3. Calculate number of vials: Total dose (mg) ÷ 100 mg per vial, rounded up to nearest whole number

Practical Examples:

  • 60 kg patient: 60 × 5.4 = 324 mg → 4 vials needed
  • 70 kg patient: 70 × 5.4 = 378 mg → 4 vials needed
  • 80 kg patient: 80 × 5.4 = 432 mg → 5 vials needed
  • 84 kg patient (average used in cost calculations): 84 × 5.4 = 453.6 mg → 5 vials needed 2
  • 90 kg patient: 90 × 5.4 = 486 mg → 5 vials needed
  • 100 kg patient: 100 × 5.4 = 540 mg → 6 vials needed

Reconstitution Details

Each 100 mg vial is reconstituted with 5 mL of Sterile Water for Injection to achieve a final concentration of 20 mg/mL 1. More than one vial is typically needed for a full dose 1.

Important Preparation Considerations

  • Reconstituted vials are stable for up to 24 hours refrigerated (2-8°C) per FDA labeling 1
  • Recent stability data suggests reconstituted T-DXd maintains physical, chemical, and affinity stability for up to 4 weeks when stored at 2-8°C 3, though this extended stability is not yet reflected in official labeling
  • Any unused portion after 24 hours should be discarded per current FDA guidelines 1
  • The maximum time from reconstitution through end of administration should not exceed 24 hours 1

Cost Implications

Given that most patients require 4-6 vials per infusion and each vial costs approximately $2,460 (based on Medicare reimbursement of $24.60/mg × 100 mg), drug cost alone ranges from $9,840 to $14,760 per cycle, with the average cost around $11,158.56 for an 84 kg patient 2. This does not include administration costs or facility charges.

The single-dose vial design with mandatory 24-hour discard creates significant waste, as partial vials cannot be saved between patients under current labeling 1, 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.